Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors (ART0380C001)

  • Details

ClinicalTrials.gov ID: NCT04657068
Diagnosis Type: Solid Tumors
USOR Number: 23292

  • Practice Details

8820 Huron St
Thornton, CO 80260
P: (303) 386-7622

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors (ART0380C001)

  • Details

ClinicalTrials.gov ID: NCT04657068
Diagnosis Type: Solid Tumors
USOR Number: 23292

  • Practice Details

11750 W 2nd Place, Suite 160
Lakewood, CO 80228
P: (303) 430-2700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors (ART0380C001)

  • Details

ClinicalTrials.gov ID: NCT04657068
Diagnosis Type: Solid Tumors
USOR Number: 23292

  • Practice Details

22 W Dry Creek Circle
Littleton, CO 80120
P: (303) 730-4700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Lone Tree

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors (ART0380C001)

  • Details

ClinicalTrials.gov ID: NCT04657068
Diagnosis Type: Solid Tumors
USOR Number: 23292

  • Practice Details

10107 RidgeGate Parkway, Suite 200
Lone Tree, CO 80124
P: (303) 925-0700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors (ART0380C001)

  • Details

ClinicalTrials.gov ID: NCT04657068
Diagnosis Type: Solid Tumors
USOR Number: 23292

  • Practice Details

6031 East Woodmen Road, Suite 200
Colorado Springs, CO 80923
P: (719) 577-2555

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors (ART0380C001)

  • Details

ClinicalTrials.gov ID: NCT04657068
Diagnosis Type: Solid Tumors
USOR Number: 23292

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, CO 80907
P: (719) 577-2555

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors (ART0380C001)

  • Details

ClinicalTrials.gov ID: NCT04657068
Diagnosis Type: Solid Tumors
USOR Number: 23292

  • Practice Details

4700 E Hale Parkway, Suite 400
Denver, CO 80220
P: (303) 321-0302

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors (ART0380C001)

  • Details

ClinicalTrials.gov ID: NCT04657068
Diagnosis Type: Solid Tumors
USOR Number: 23292

  • Practice Details

1800 N Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors (ART0380C001)

  • Details

ClinicalTrials.gov ID: NCT04657068
Diagnosis Type: Solid Tumors
USOR Number: 23292

  • Practice Details

4715 Arapahoe Avenue
Boulder, CO 80303
P: (303) 385-2068

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Centennial

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients with Advanced or Metastatic Solid Tumors (ART0380C001)

  • Details

ClinicalTrials.gov ID: NCT04657068
Diagnosis Type: Solid Tumors
USOR Number: 23292

  • Practice Details

14000 E. Arapahoe Rd. Ste. 160
Centennial, CO 80112
P: 303-805-7744

More Details View Practice Page
1 2 3 54